Recorded fact · drug.label_indication
drug.label_indication for ixekizumab|psoriasis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact a88cb8f9 resolves to.
The record
| Fact id | a88cb8f994a6cc985fc1980d |
|---|---|
| Entity | drug: ixekizumab|psoriasis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260122 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: bf61c4c617d36eb068095b8eeca28c22d51a5e7c6a7818c8ccc94545bba0e2fe.
The value
{
"ingredient": "Ixekizumab",
"conditionId": "psoriasis",
"conditionName": "Psoriasis",
"matchedAlias": "psoriasis",
"context": "indication",
"brand": "TALTZ",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "ac96658a-d7dc-4c7c-8928-2adcdf4318b2",
"labelEffectiveTime": "20260122",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 6499c7b13ac47d814d3ef74862a64f9f9591e2f213ba4dbbe7b1730dfe7de661.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.